GlassScriptPhysician profile
Tai-Won Kim
NPI 1487733754
$1,235.20
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $716 · 2020: $452 · 2021: $66.63.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $196.33 | 2019 | |
| Lilly USA, LLC | $191.42 | 2019-2020 | |
| Glaxosmithkline, LLC. | $158.54 | 2019-2020 | |
| Amarin Pharma, INC. | $115.08 | 2020 | |
| Astellas Pharma US INC | $111.01 | 2019 | |
| Allergan, INC. | $72.83 | 2019-2020 | |
| Novo Nordisk INC | $56.24 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $54.03 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.53 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.73 | 2020 | |
| Abbvie INC. | $42.07 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $39.30 | 2020 | |
| Amgen INC. | $25.72 | 2019 | |
| Dermira, INC. | $17.56 | 2020 | |
| Nestle Healthcare Nutrition INC. | $15.60 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $13.88 | 2021 | |
| Pfizer INC. | $13.41 | 2020 | |
| Sun Pharmaceutical Industries INC. | $11.92 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tai-Won Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.